Degroof Petercam Asset Management Neurocrine Biosciences Inc Transaction History
Degroof Petercam Asset Management
- $8.32 Trillion
- Q1 2024
A detailed history of Degroof Petercam Asset Management transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Degroof Petercam Asset Management holds 2,600 shares of NBIX stock, worth $300,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,600
Previous 2,600
-0.0%
Holding current value
$300,560
Previous $343 Million
4.68%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$565 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$349 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$293 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...